(Yicai) Jan. 26 -- About the performance of the Chinese stock market over the past one and a half years, the chief China economist at Japanese securities brokerage Nomura Holdings gave it a full score ... ( read original story ...)
Chinese drinks maker Eastroc’s US$1.3 billion Hong Kong IPO gives it wings to soar
Shanghai-listed firm is selling 40.9 million shares for HK$248 each, which would give it a market cap of about US$21 billion. ( read original story ...)
Chinese tech listings shine in Hong Kong, fuelled by Beijing’s self-reliance push
Outperformance so far this year shows the theme remains a boon for investors in a challenging environment, analysts say. ( read original story ...)
China’s Eastroc Beverage seeks up to US$1.3 bil from Hong Kong listing
Chinese energy-drink maker Eastroc Beverage Group Co has started taking investor orders for its second listing in Hong Kong that may fetch as much as HK$10.1 billion (US$1.3 billion, or $1.64 billion) ... ( read original story ...)
Shanghai’s Roadmap for the Next Decade: Finance, AI, Green Tech
The city’s new five-year plan outlines economic priorities through 2030 and sets a long-term goal of doubling per capita GDP. ( read original story ...)
China’s rocket start-ups push the envelope as IPOs gather pace
A policy-backed push to build commercial space champions is reshaping China’s IPO pipeline, with regulators signalling faster pathways. ( read original story ...)
China’s Fosun Pharma eyes spin-off listing of vaccine unit in hot Hong Kong IPO market
Fosun Adgenvax (Chengdu) joins an IPO wave that raised more than US$1.5 billion last year for biotech companies The board of Shanghai Fosun Pharmaceutical approved the spin-off and Hong Kong listing ... ( read original story ...)